OakChart

Stereotaxis Inc

STXSHealthcare·Medical Instruments & Supplies·USA·Micro·AMEX·Nov 11 • 1:05 PM ET

0.8751-0.1549 (-15.04%)
2026-11-11 19:05 CET
Market cap
103.21 USD m
Revenue, TTM
31.53 USD m
Net income, TTM
-23.60 USD m
Free cash flow, TTM
- USD m
EPS diluted, TTM
-0.24
P/E
-
Compare

Price

STXS against its 20, 50 and 200-day averages
2050200beatmiss
1.001.502.002.502.9M5.7MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26STXSclose 0.8820-day 0.9950-day 1.15200-day 1.640.88

69.7% under the 52-week high of 2.89 on 11 Nov 2025. 52-week low 0.80 on 3 Nov 2026. Last 15 sessions, 53.1% high to low

Profile

STXS
52-week range, 4% of the way up
0.802.89

Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.

IndexRUT
Employees131
IPOAug 12, 2004
Beta1.36
ATR, 14d0.10
Rel volume5.25
Short float7.22%
Insider own23.21%
Inst own43.15%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap87.69M
Enterprise Value96.79M
Income-23.60M
Sales31.53M
Book/sh0.21
Cash/sh0.04
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees131
IPOAug 12, 2004

Ratios

P/E-
Forward P/E-
PEG-
P/S2.78
P/B4.13
P/C22.03
P/FCF-
EV/EBITDA-
EV/Sales3.07
Quick Ratio0.67
Current Ratio1.08
Debt/Eq0.30
LT Debt/Eq0.25
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.24
EPS next Y-0.16
EPS next Q-0.05
EPS this Y13.33%
EPS next Y27.69%
EPS next 5Y-
EPS past 3/5Y0.82% -17.98%
Sales past 3/5Y4.78% 3.99%
EPS Y/Y TTM13.55%
Sales Y/Y TTM4.83%
EPS Q/Q10.04%
Sales Q/Q19.57%
EarningsNov 10 AMC
EPS/Sales Surpr.-31.33% -38.54%

Ownership

Insider Own23.21%
Insider Trans0.00%
Inst Own43.15%
Inst Trans-0.84%
ROA-34.99%
ROE-117.39%
ROIC-67.55%
Gross Margin56.33%
Oper. Margin-66.22%
Profit Margin-74.86%
SMA20-11.20%
SMA50-23.76%
SMA200-46.70%
Trades-

Technical

Shs Outstand100.83M
Shs Float76.94M
Short Float7.22%
Short Ratio8.95
Short Interest5.56M
52W High2.89 -69.72%
52W Low0.80 9.39%
Volatility15.01% 9.09%
ATR (14)0.10
RSI (14)38.12
Beta1.36
Rel Volume5.25
Avg Volume620.99K
Volume1,871,750

Performance

Perf Week-8.58%
Perf Month-17.44%
Perf Quarter-36.59%
Perf Half Y-52.70%
Perf YTD-61.95%
Perf Year-69.29%
Perf 3Y-40.47%
Perf 5Y-87.02%
Perf 10Y56.27%
Recom1.00
Target Price2.67
Prev Close1.03
Price0.88
Change %-15.04%

Analyst ratings

latest 10 of 10
DateActionAnalystRating changeTargetImplied
Dec 16, 2025InitiatedCCitizens JMPMkt Outperform$4+357.1%
Jan 10, 2024InitiatedRROTH MKMBuy$5+471.4%
Jul 12, 2022InitiatedAAegis CapitalBuy$6+585.6%
Jun 23, 2022InitiatedRB. Riley SecuritiesBuy$6+585.6%
Jan 05, 2022InitiatedLLoop CapitalBuy$13+1,385.5%
Jan 05, 2022InitiatedCCraig HallumBuy$11+1,157.0%
May 26, 2021InitiatedPPiper SandlerOverweight$9+928.5%
Sep 08, 2020InitiatedNNorthland CapitalOutperform$9.50+985.6%
Apr 09, 2020InitiatedCCowenOutperform$6+585.6%
Apr 07, 2020InitiatedLLake StreetBuy$5+471.4%

Peers

Mkt cap
TickerCompanyMkt cap
PLSEPulse Biosciences Inc4.16B
ATRCAtricure Inc2.87B
BSXBoston Scientific Corp65.96B
MBOTMicrobot Medical Inc73.84M
ABTAbbott Laboratories190.70B
ISRGIntuitive Surgical Inc154.16B
JNJJohnson & Johnson668.88B
MDTMedtronic Plc129.16B
PRCTProcept BioRobotics Corp1.32B
KMTSKestra Medical Technologies Ltd1.81B

Insider trading

2 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Isaac Paul JDirectorNov 14 '25Buy2.2420,00044,8002,786,557Nov 18 03:22 PM
Isaac Paul JDirectorNov 17 '25Buy2.1810,00021,80097,299Nov 18 03:22 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
IWCiShares Micro-Cap ETFAUM: 1.22B
BUSMEA Bridgeway Ultra-Small Company Market ETFAUM: 111.21M
VTWGVanguard Russell 2000 Growth Index ETFAUM: 1.41B
RSSLGlobal X Russell 2000 ETFAUM: 1.43B
VTHRVanguard Russell 3000 Index ETFAUM: 4.81B

News

latest 14 of 206
  • Stereotaxis' Capital-System Momentum Is Overshadowed By Catheter Supply Shortfalls, Margin Compression, And A Forced Convertible Raise (Earnings Whispers) -9.65% -15.04%
  • Stereotaxis Reports 2026 Third Quarter Financial Results & Business Updates (GlobeNewswire)
  • Stereotaxis Announces Convertible Note Financing of Up To $24 Million (GlobeNewswire)
  • Stereotaxis Must Prove Its Lowered Catheter-Led Plan Holds As Cash Thins (Earnings Whispers)
  • First-in-Human Coronary Intervention Study Results of Robocath's Next-Generation Robotic System Highlighted at TCT (GlobeNewswire)
  • Loading…
  • Canon Medical and Stereotaxis Collaborate to Advance Robotic Electrophysiology (GlobeNewswire) -5.21%
  • Stereotaxis Announces First Robotic Magnetic Navigation System in Latvia (GlobeNewswire)
  • Stereotaxis to Report Third Quarter 2026 Financial Results on November 10, 2026 (GlobeNewswire)
  • Stereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart Rhythm Society's HRX 2026 (GlobeNewswire)
  • University of Szeged Celebrates Strongest First Month of Robotic Cardiology Program (GlobeNewswire)
  • Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates (GlobeNewswire)
  • Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026 (GlobeNewswire)
  • University of Szeged Pioneers First Robotic Cardiology Program in Hungary (GlobeNewswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-10-0.070-0.053-0.0665.909.603
2026Q22026-08-11-0.050-0.050-0.0487.678.354
2026Q12026-05-12-0.060-0.050-0.0626.298.504
2025Q42026-03-09-0.060-0.063-0.0618.649.084
2025Q32025-11-11-0.070-0.060-0.0747.468.384
2025Q22025-08-07-0.050-0.065-0.0478.808.134
2025Q12025-05-12-0.070-0.073-0.0707.476.884
2024Q42025-03-03-0.090-0.065-0.0906.347.084
2024Q32024-11-11-0.080-0.053-0.0769.207.104
2024Q22024-08-12-0.070-0.053-0.0734.505.634
2024Q12024-05-13-0.060-0.062-0.0586.887.005
2023Q42024-03-04-0.070-0.066-0.0654.577.705
2023Q32023-11-09-0.070-0.060-0.0697.808.285
2023Q22023-08-10-0.070-0.072-0.0657.866.685
2023Q12023-05-09-0.070-0.058-0.0746.556.634
2022Q42023-03-03-0.060-0.067-0.0597.308.506

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2014FY-0.440--0.260--
2015FY-0.410--0.350--
2017FY-0.013--0.32031.14-
2019FY-0.100--0.09628.90-
2020FY-0.110-0.120-0.11026.6325.87
2021FY-0.160-0.165-0.16035.0234.10
2022FY-0.260-0.267-0.25828.1529.37
2023FY-0.270-0.278-0.27326.7729.90
2024FY-0.300-0.268-0.29826.9227.23
2025FY-0.250-0.255-0.30032.3832.78
2026FY--0.217--33.27
2027FY--0.157--43.33

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-1130210.039.1011.00
2026Q4S2026-11-1030010.7310.2011.00
2026Q4S2026-11-0930010.7310.2011.00
2026Q4S2026-10-2630110.7310.2011.00
2026Q4S2026-08-2630310.7310.2011.00
2026Q4S2026-08-1630211.4710.2013.20
2026Q4S2026-08-1231211.4710.2013.20
2026Q4S2026-07-2741013.7513.0014.70
2026Q4S2026-06-0244013.7513.0014.70
2026Q4S2026-05-1343112.608.6014.70
2026Q4S2026-05-0640211.9511.5012.70
2026Q4S2026-03-3150311.9811.5012.70
2026Q4S2026-03-1250212.1411.6012.70
2026Q4S2026-03-1040212.2812.0012.70

Estimate history

EPS, annual-0.32-0.025-0.096-0.11-0.16-0.258-0.273-0.298-0.252-0.2374
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.076-0.09-0.07-0.047-0.074-0.061-0.062-0.048-0.066
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual31.14429.34728.90326.6335.02128.14726.77126.91832.37731.53
Period201720182019202020212022202320242025TTM
Sales, quarterly9.1966.347.4728.7987.4648.6426.2917.678.925
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual22.80259.05468.5373.6974.61474.8780.94685.32395.336100.829
Period201720182019202020212022202320242025MRQ
Shares, quarterly84.70985.32385.9886.00191.08495.33697.48797.934100.829
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue31.5332.3826.9226.7728.1535.0226.6328.9029.35
Cost of Goods Sold Incl. D&A13.7715.3112.3211.919.6811.797.666.145.72
Gross Profit17.7617.0714.5914.8618.4723.2318.9722.7723.63
Selling, General and Administrative Excl. Other37.4437.4839.3336.7037.2536.1225.6827.5925.99
Research and Development11.029.389.7610.2710.5610.208.149.028.13
Other Operating Expense0.00-0.490.000.000.000.000.000.000.00
Operating Income-19.68-19.91-24.74-21.84-18.78-12.89-6.71-4.83-2.36
Interest Expense-----0.01-0.000.00
Unusual Expense-2.200.000.000.00-2.180.000.00-2.50
Net Income Before Taxes-22.34-21.64-24.05-20.71-18.29-10.72-6.65-4.590.12
Income Taxes0.000.000.000.000.000.000.000.000.00
Consolidated Net Income-22.34-21.64-24.05-20.71-18.29-10.72-6.65-4.590.12
Net Income From Continuing Operations-22.34-21.64-24.05-20.71-18.29-10.72-6.65-4.590.12
Net Income-23.60-22.91-25.35-22.06-19.64-12.06-8.02-6.02-1.32
EPS (Recurring)-0.23-0.23-0.30-0.27-0.26-0.18-0.11-0.10-0.06
EPS (Basic, Before Extraordinaries)-0.24-0.25-0.30-0.27-0.26-0.16-0.11-0.10-0.03
EPS (Diluted)-0.24-0.25-0.30-0.27-0.26-0.16-0.11-0.10-0.03
EBITDA--18.36-23.77-21.24-18.24-12.78-6.59-4.70-1.78
Non-Operating Income (Expense)0.370.470.691.130.480.000.070.24-0.02
Other After Tax Adjustments-0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense-9.8510.2610.6210.589.363.171.810.56
Price To Sales Ratio-6.467.225.285.5913.3813.9011.541.92
Gross Margin56.3352.7354.2255.5165.6266.3471.2278.7780.52
Operating Margin-66.22-61.50-91.91-81.58-66.71-36.80-25.21-16.70-8.05
Net Margin-74.86-70.77-94.19-82.39-69.76-34.44-30.10-20.83-4.49
Shares Outstanding100.8395.3485.3280.9574.8774.6173.6968.5359.05
Market Capitalization103.21103.21193.18141.55159.41475.78385.91363.1666.09

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue8.937.676.298.647.468.807.476.34
Cost of Goods Sold Incl. D&A4.973.182.504.323.364.223.413.12
Gross Profit3.964.493.794.334.104.584.063.22
Selling, General and Administrative Excl. Other10.438.458.979.599.319.059.9910.84
Research and Development3.522.392.402.712.551.782.352.79
Other Operating Expense0.000.000.000.000.00-0.490.000.00
Operating Income-6.47-3.97-5.18-5.26-5.21-3.98-5.93-7.63
Interest Expense-0.00------
Unusual Expense-0.600.800.391.350.000.000.00
Net Income Before Taxes-6.48-4.47-5.86-5.53-6.46-3.83-5.82-7.51
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-6.48-4.47-5.86-5.53-6.46-3.83-5.82-7.51
Net Income From Continuing Operations-6.48-4.47-5.86-5.53-6.46-3.83-5.82-7.51
Net Income-6.80-4.78-6.17-5.85-6.79-4.14-6.14-7.84
EPS (Recurring)-0.07-0.04-0.06-0.06-0.06-0.05-0.07-0.09
EPS (Basic, Before Extraordinaries)-0.07-0.05-0.06-0.06-0.07-0.05-0.07-0.09
EPS (Diluted)-0.07-0.05-0.06-0.06-0.07-0.05-0.07-0.09
EBITDA--3.56-4.79-4.86-4.82-3.58-5.56-7.26
Non-Operating Income (Expense)0.030.100.120.120.090.150.110.11
Other After Tax Adjustments-0.000.000.000.000.000.000.00
Stock Option Compensation Expense-1.272.112.452.502.372.542.57
Price To Sales Ratio-5.725.836.829.525.865.627.35
Gross Margin44.3258.4960.3150.0754.9452.0554.3950.73
Operating Margin-72.50-51.73-82.36-60.85-69.75-45.20-79.35-120.30
Net Margin-76.17-62.35-98.11-67.68-90.90-47.10-82.13-123.64
Shares Outstanding100.8397.9397.4995.3491.0886.0085.9885.32
Market Capitalization103.21168.11178.94214.65283.23182.32151.32193.18

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments13.4212.4420.3428.9539.1944.1930.1810.803.69
Short Term Receivables10.163.823.825.295.413.525.335.024.29
Inventories9.578.338.437.884.433.301.851.191.15
Other Current Assets0.601.750.581.122.361.721.470.960.75
Total Current Assets33.7526.3433.1743.2551.3952.7238.8317.979.87
Net Property, Plant & Equipment7.939.068.299.218.372.434.540.340.59
Total Investments and Advances0.000.000.220.740.950.000.000.000.00
Intangible Assets10.1911.12-----0.000.16
Other Assets0.380.210.240.210.280.310.220.200.04
Total Assets52.2546.7241.9153.4160.9855.4643.5818.5110.67
Short Term Debt Incl. Current Port. of LT Debt0.640.570.430.370.273.472.250.000.00
Accounts Payable4.775.673.193.274.191.612.101.731.65
Other Current Liabilities16.9515.369.6310.658.808.497.818.4728.47
Total Current Liabilities22.3621.6013.2514.2913.2613.5712.1610.1930.13
Long Term Debt4.795.445.065.495.840.972.090.000.00
Provision for Risks Charges0.000.000.000.000.000.000.00-0.00
Other Liabilities6.388.251.681.712.460.680.811.051.15
Total Liabilities33.5335.2919.9921.4821.5615.2315.0611.2431.27
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value5.245.355.585.595.595.615.765.965.96
Common Equity13.486.0816.3426.3433.8334.6222.761.31-26.57
Total Shareholders Equity18.7211.4321.9231.9339.4240.2328.527.27-20.61
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity18.7211.4321.9231.9339.4240.2328.527.27-20.61
Total Liabilities & Stockholders Equity52.2546.7241.9153.4160.9855.4643.5818.5110.67
Book Value Per Share0.140.070.200.350.450.470.330.02-1.17
Tangible Book Value Per Share0.03-0.060.200.350.450.470.330.02-1.17
Full-Time Employees131139122130130120118119117
Price to Book Ratio8.2417.867.565.7413.7611.0215.9350.10-0.78
Return on Assets-43.73-54.26-43.46-31.98-18.41-13.42-14.790.80-37.22
Return on Equity-143.55-144.19-76.93-51.27-26.91-19.33-25.65--
Return on Invested Capital-92.04-142.55-76.77-48.89-23.67-16.13-15.001.61-
Quick Ratio1.080.831.872.473.543.643.041.650.29
Current Ratio1.511.222.503.033.873.883.191.760.33

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income--21.64-24.05-20.71-18.29-10.72-6.65-4.590.12
Depreciation-1.550.970.590.530.110.130.120.58
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00
Other Funds (Non Cash)-12.0212.0710.3710.459.915.513.67-1.59
Funds from Operations--8.06-11.00-9.75-7.31-0.70-1.01-0.80-0.89
Extraordinary Item-0.000.000.000.000.000.000.000.00
Changes in Working Capital--5.622.500.61-1.10-2.50-2.25-3.82-1.65
Cash from Operating Activities--13.69-8.50-9.14-8.41-3.20-3.26-4.62-2.55
Capital Expenditures--0.09-0.03-0.37-2.38-1.40-0.07-0.03-0.27
Net Assets From Acquisitions-0.000.000.000.000.000.000.00-
Sale of Fixed Assets and Businesses-0.000.110.000.000.000.000.00-
Purchase or Sale of Investments-0.000.0020.13-19.720.000.000.000.00
Purchase of Investments-0.000.000.00-19.720.000.000.000.00
Sale Or Maturity of Investments-0.000.0020.130.000.000.000.000.00
Other Uses-0.000.000.000.000.000.000.000.00
Other Sources-0.000.000.000.000.000.000.000.00
Cash from Investing Activities--0.090.0719.77-22.09-1.40-0.07-0.03-0.27
Cash Dividends Paid-0.000.000.000.000.000.000.000.00
Change in Capital Stock-14.760.300.080.220.5515.1824.039.92
Repurchase of Common Pref Stock-0.000.000.000.000.000.000.000.00
Sale of Common Pref Stock-14.760.300.080.220.5515.1824.039.92
Proceedsfrom Stock Options-14.760.300.080.220.5515.1824.030.06
Issuance or Reduction of Debt, Net-0.000.000.000.000.002.160.000.00
Change in Long Term Debt-0.000.000.000.000.002.160.000.00
Issuance of Long Term Debt-0.000.000.000.000.002.160.000.00
Reduction of Long Term Debt-0.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow-0.000.000.000.000.000.000.000.00
Other Financing Activities Uses-0.000.000.000.000.000.000.000.00
Cash from Financing Activities-14.760.300.080.220.5517.3424.039.92
Net Change in Cash-0.98-8.1310.71-30.29-4.0514.0119.397.11
Free Cash Flow--13.78-8.53-9.51-10.79-4.59-3.33-4.65-2.81

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments3.9810.4914.6213.4210.516.97
Short Term Receivables15.5713.879.6210.165.334.39
Inventories13.2712.5210.499.5710.159.61
Other Current Assets1.630.911.100.600.680.84
Total Current Assets34.4437.7935.8333.7526.6621.80
Net Property, Plant & Equipment9.057.547.727.938.218.49
Total Investments and Advances1.700.000.000.000.000.00
Intangible Assets36.269.729.9610.1910.4310.66
Other Assets0.660.540.530.380.280.22
Total Assets82.1155.5854.0352.2545.5941.17
Short Term Debt Incl. Current Port. of LT Debt1.360.690.660.640.620.60
Accounts Payable7.726.874.824.774.686.73
Other Current Liabilities22.6819.2417.6016.9515.0713.41
Total Current Liabilities31.7626.8023.0922.3620.3720.75
Long Term Debt6.554.484.624.794.965.12
Provision for Risks Charges-0.000.000.000.000.00
Other Liabilities17.276.826.736.388.728.55
Total Liabilities55.5838.1034.4333.5334.0534.42
Non-Equity Reserves-0.000.000.000.000.00
Preferred Stock - Carrying Value5.175.235.245.245.275.30
Common Equity21.3612.2414.3613.486.271.46
Total Shareholders Equity26.5317.4819.6018.7211.536.75
Accumulated Minority Interest-0.000.000.000.000.00
Total Equity26.5317.4819.6018.7211.536.75
Total Liabilities & Stockholders Equity82.1155.5854.0352.2545.5941.17
Book Value Per Share0.210.130.150.140.070.02
Tangible Book Value Per Share-0.150.030.050.03-0.05-0.11
Full-Time Employees---131--
Price to Book Ratio8.2413.7612.4933.44183.7063.28
Return on Assets-34.99-46.14-43.48-43.73-48.96-60.51
Return on Equity-117.39-184.27-156.12-143.55-170.24-198.62
Return on Invested Capital-19.60-20.35-24.20-23.52-39.18-32.22
Quick Ratio0.670.941.101.080.810.59
Current Ratio1.081.411.551.511.311.05

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income--4.47-5.86-5.53-6.46-3.83
Depreciation-0.410.400.400.390.40
Other Funds (Non Cash)-2.252.862.813.852.32
Funds from Operations--1.82-2.60-2.33-2.22-1.10
Extraordinary Item-0.000.000.000.000.00
Changes in Working Capital--1.86-0.84-1.64-1.99-2.63
Cash from Operating Activities--3.67-3.44-3.97-4.20-3.73
Capital Expenditures--0.06-0.08-0.070.00-0.02
Net Assets From Acquisitions--1.080.000.000.000.00
Sale of Fixed Assets and Businesses-0.000.000.000.000.00
Purchase or Sale of Investments-0.000.000.000.000.00
Purchase of Investments-0.000.000.000.000.00
Sale Or Maturity of Investments-0.000.000.000.000.00
Other Uses-0.000.000.000.000.00
Other Sources-0.000.000.000.000.00
Cash from Investing Activities--1.15-0.08-0.070.00-0.02
Cash Dividends Paid-0.000.000.000.000.00
Change in Capital Stock-0.694.726.957.740.03
Repurchase of Common Pref Stock-0.000.000.000.000.00
Sale of Common Pref Stock-0.694.726.957.740.03
Proceedsfrom Stock Options-0.694.726.957.740.03
Issuance or Reduction of Debt, Net-0.000.000.000.000.00
Change in Long Term Debt-0.000.000.000.000.00
Issuance of Long Term Debt-0.000.000.000.000.00
Reduction of Long Term Debt-0.000.000.000.000.00
Net Financing Active Other Cash Flow-0.000.000.000.000.00
Other Financing Activities Uses-0.000.000.000.000.00
Cash from Financing Activities-0.694.726.957.740.03
Net Change in Cash--4.121.202.923.54-3.72
Free Cash Flow--3.74-3.52-4.04-4.20-3.76

Revenue breakdown

Disposables Service and Accessories2024: 18.29M 2025: 22.15M
Systems2024: 8.63M 2025: 10.22M
Non-US2024: 13.49M 2025: 19.51M
United States2024: 13.43M 2025: 12.87M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-307.22%5.6M76.9M594.24K
2026-10-157.79%6.0M76.9M805.99K
2026-09-307.38%5.7M76.9M821.95K
2026-09-157.25%5.6M76.9M859.80K
2026-08-316.57%5.1M76.9M815.95K
2026-08-146.53%5.4M82.5M800.62K
2026-07-315.56%4.5M80.6M735.75K
2026-07-155.53%4.5M80.6M469.95K
2026-06-305.30%4.3M80.4M427.10K
2026-06-154.68%3.8M82.2M382.71K
2026-05-294.72%3.9M82.2M417.88K
2026-05-154.62%3.8M82.2M419.70K
2026-04-304.43%3.6M81.9M450.68K
2026-04-154.12%3.3M80.8M456.96K
2026-03-314.38%3.5M80.8M518.45K
2026-03-134.16%3.4M80.8M526.01K
2026-02-273.88%3.0M77.5M494.55K
2026-02-134.22%3.3M77.5M524.97K
2026-01-303.48%2.7M77.5M572.26K
2026-01-153.67%2.8M77.5M563.28K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.500.000.050.054.9601,4820.000.180-0.0100.000
call5.000.000.100.106.0871600.000.139-0.0120.000
call7.500.000.050.057.0613.000.000.128-0.0130.000
put2.500.104.901.550.0004.000.00-0.819-0.0100.000
put5.003.606.500.000.0000.000.00-0.850-0.0120.000
put7.504.609.000.000.0000.000.00-0.861-0.0130.000

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-108-KCurrent report2026-11-09SEC
2026-08-19SCHEDULE 13GSEC
2026-08-13EFFECTEffectiveness filing by commission orderSEC
2026-08-13EFFECTEffectiveness filing by commission orderSEC
2026-08-13424B3SEC
2026-08-13424B3SEC
2026-08-1210-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-118-KCurrent report2026-08-11SEC
2026-07-168-KCurrent report2026-07-15SEC
2026-07-15S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-07-15S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-07-098-KCurrent report2026-07-07SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-05-29SDSpecialized Disclosure ReportSEC
2026-05-15SCHEDULE 13G/ASEC
2026-05-158-KCurrent report2026-05-14SEC
2026-05-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-128-KCurrent report2026-05-12SEC
2026-04-158-KCurrent report2026-04-14SEC
2026-04-134Statement of changes in beneficial ownership of securities2026-04-11SEC
2026-04-0310-K/A2025-12-31SEC
2026-04-03DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-03DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-04-03SEC
2026-03-20EFFECTEffectiveness filing by commission orderSEC
2026-03-18CORRESPSEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-1166.60K200

Institutional holders

Manager% owned
DAFNA Capital Management LLC14.00%
Arbiter Partners Capital Management LLC5.90%
BlackRock, Inc.4.50%
Lagoda Investment Management, L.P.4.22%
VANGUARD CAPITAL MANAGEMENT LLC3.12%
GEODE CAPITAL MANAGEMENT, LLC1.90%
ESSEX INVESTMENT MANAGEMENT CO LLC1.56%
Archon Capital Management LLC1.25%
Warberg Asset Management LLC1.13%
STATE STREET CORP0.94%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.03%
iShares Russell 2000 ETF1.67%
VANGUARD EXTENDED MARKET INDEX FUND1.01%
Fidelity Small Cap Index Fund0.75%
iShares Russell 2000 Growth ETF0.66%
AlphaCentric Robotics and Automation Fund0.61%
Fidelity Extended Market Index Fund0.44%
VANGUARD RUSSELL 2000 INDEX FUND0.39%
1290 Essex Small Cap Growth Fund0.38%
iShares Micro-Cap ETF0.23%

OakChart. STXS. Cached 15 minutes.